prospect hospice limited
prospect hospice limited Company Information
Company Number
01494909
Website
www.prospect-hospice.netRegistered Address
moormead road wroughton, swindon, wiltshire, SN4 9BY
Industry
Hospital activities
Other human health activities
Telephone
01793816124
Next Accounts Due
December 2025
Group Structure
View All
Shareholders
-0%
prospect hospice limited Estimated Valuation
Pomanda estimates the enterprise value of PROSPECT HOSPICE LIMITED at £4.7m based on a Turnover of £7.4m and 0.64x industry multiple (adjusted for size and gross margin).
prospect hospice limited Estimated Valuation
Pomanda estimates the enterprise value of PROSPECT HOSPICE LIMITED at £0 based on an EBITDA of £-1.1m and a 5.3x industry multiple (adjusted for size and gross margin).
prospect hospice limited Estimated Valuation
Pomanda estimates the enterprise value of PROSPECT HOSPICE LIMITED at £17m based on Net Assets of £6.6m and 2.58x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Prospect Hospice Limited Overview
Prospect Hospice Limited is a live company located in wiltshire, SN4 9BY with a Companies House number of 01494909. It operates in the hospital activities sector, SIC Code 86101. Founded in May 1980, it's largest shareholder is unknown. Prospect Hospice Limited is a mature, mid sized company, Pomanda has estimated its turnover at £7.4m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Prospect Hospice Limited Health Check
Pomanda's financial health check has awarded Prospect Hospice Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £7.4m, make it larger than the average company (£2.3m)
£7.4m - Prospect Hospice Limited
£2.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (8%)
1% - Prospect Hospice Limited
8% - Industry AVG
Production
with a gross margin of 38.2%, this company has a comparable cost of product (38.2%)
38.2% - Prospect Hospice Limited
38.2% - Industry AVG
Profitability
an operating margin of -16.9% make it less profitable than the average company (8.5%)
-16.9% - Prospect Hospice Limited
8.5% - Industry AVG
Employees
with 197 employees, this is above the industry average (28)
197 - Prospect Hospice Limited
28 - Industry AVG
Pay Structure
on an average salary of £31.3k, the company has an equivalent pay structure (£29.1k)
£31.3k - Prospect Hospice Limited
£29.1k - Industry AVG
Efficiency
resulting in sales per employee of £37.7k, this is less efficient (£58.7k)
£37.7k - Prospect Hospice Limited
£58.7k - Industry AVG
Debtor Days
it gets paid by customers after 13 days, this is earlier than average (21 days)
13 days - Prospect Hospice Limited
21 days - Industry AVG
Creditor Days
its suppliers are paid after 8 days, this is quicker than average (26 days)
8 days - Prospect Hospice Limited
26 days - Industry AVG
Stock Days
it holds stock equivalent to 5 days, this is less than average (12 days)
5 days - Prospect Hospice Limited
12 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 65 weeks, this is less cash available to meet short term requirements (93 weeks)
65 weeks - Prospect Hospice Limited
93 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 10%, this is a lower level of debt than the average (35.8%)
10% - Prospect Hospice Limited
35.8% - Industry AVG
PROSPECT HOSPICE LIMITED financials
Prospect Hospice Limited's latest turnover from March 2024 is £7.4 million and the company has net assets of £6.6 million. According to their latest financial statements, Prospect Hospice Limited has 197 employees and maintains cash reserves of £920 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 7,427,000 | 8,162,000 | 7,228,000 | 7,125,000 | 7,261,000 | 7,649,000 | 7,742,000 | 7,556,000 | 8,178,000 | 7,679,000 | 7,380,000 | 7,830,000 | 6,279,000 | 6,145,309 | 5,260,106 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | -1,241,000 | 604,000 | -476,000 | -278,000 | -1,863,000 | -1,383,000 | -625,000 | -495,000 | 380,000 | -7,212,000 | 1,115,000 | 1,999,000 | 106,000 | 1,021,596 | 254,078 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -1,241,000 | 604,000 | -476,000 | -278,000 | -1,863,000 | -1,383,000 | -625,000 | -495,000 | 380,000 | -7,212,000 | 1,115,000 | 1,999,000 | 106,000 | 1,021,596 | 254,078 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -1,241,000 | 604,000 | -476,000 | -278,000 | -1,863,000 | -1,383,000 | -625,000 | -495,000 | 380,000 | -7,212,000 | 1,115,000 | 1,999,000 | 106,000 | 1,021,596 | 254,078 |
| Employee Costs | 6,161,000 | 5,163,000 | 5,554,000 | 5,611,000 | 6,442,000 | 6,396,000 | 6,039,000 | 5,822,000 | 5,575,000 | 4,943,000 | 4,366,000 | 3,975,000 | 3,782,000 | 3,528,899 | 3,326,799 |
| Number Of Employees | 197 | 190 | 196 | 185 | 206 | 211 | 207 | 190 | 188 | 156 | 135 | 127 | 116 | 115 | 109 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,286,000 | 2,296,000 | 2,389,000 | 2,688,000 | 2,878,000 | 3,143,000 | 3,183,000 | 3,125,000 | 3,459,000 | 3,204,000 | 3,075,000 | 2,722,000 | 2,829,000 | 2,893,712 | 2,516,570 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 3,338,000 | 4,279,000 | 4,355,000 | 4,017,000 | 3,816,000 | 4,686,000 | 5,871,000 | 5,707,000 | 4,832,000 | 4,526,000 | 3,220,000 | 2,079,000 | 1,776,000 | 1,800,848 | 1,727,585 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 5,624,000 | 6,575,000 | 6,744,000 | 6,705,000 | 6,694,000 | 7,829,000 | 9,054,000 | 8,832,000 | 8,291,000 | 7,730,000 | 6,295,000 | 4,801,000 | 4,605,000 | 4,694,560 | 4,244,155 |
| Stock & work in progress | 63,000 | 55,000 | 44,000 | 54,000 | 71,000 | 93,000 | 85,000 | 77,000 | 63,000 | 56,000 | 12,000 | 10,000 | 12,000 | 11,505 | 6,062 |
| Trade Debtors | 270,000 | 142,000 | 923,000 | 350,000 | 740,000 | 68,000 | 181,000 | 363,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 416,000 | 315,000 | 577,000 | 511,000 | 217,000 | 285,000 | 267,000 | 583,000 | 672,000 | 1,216,000 | 565,000 | 705,000 | 408,000 | 137,999 | 115,288 |
| Cash | 920,000 | 2,564,000 | 1,476,000 | 670,000 | 696,000 | 1,093,000 | 853,000 | 1,152,000 | 1,879,000 | 1,413,000 | 3,355,000 | 3,536,000 | 1,928,000 | 1,437,164 | 971,254 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,669,000 | 3,076,000 | 3,020,000 | 1,585,000 | 1,724,000 | 1,539,000 | 1,386,000 | 2,175,000 | 2,614,000 | 2,685,000 | 3,932,000 | 4,251,000 | 2,348,000 | 1,586,668 | 1,092,604 |
| total assets | 7,293,000 | 9,651,000 | 9,764,000 | 8,290,000 | 8,418,000 | 9,368,000 | 10,440,000 | 11,007,000 | 10,905,000 | 10,415,000 | 10,227,000 | 9,052,000 | 6,953,000 | 6,281,228 | 5,336,759 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 110,000 | 100,000 | 119,000 | 1,000 | 48,000 | 114,000 | 19,000 | 297,000 | 345,000 | 180,000 | 235,000 | 203,000 | 188,000 | 179,678 | 222,863 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 300,000 | 225,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 619,000 | 574,000 | 996,000 | 1,002,000 | 1,456,000 | 719,000 | 734,000 | 495,000 | 493,000 | 438,000 | 655,000 | 481,000 | 489,000 | 499,136 | 517,292 |
| total current liabilities | 729,000 | 974,000 | 1,340,000 | 1,003,000 | 1,504,000 | 833,000 | 753,000 | 792,000 | 838,000 | 618,000 | 890,000 | 684,000 | 677,000 | 678,814 | 740,155 |
| loans | 0 | 1,000,000 | 1,275,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 254,000 | 508,000 | 580,000 | 0 | 100,000 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 1,000,000 | 1,275,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 254,000 | 508,000 | 580,000 | 0 | 100,000 |
| total liabilities | 729,000 | 1,974,000 | 2,615,000 | 1,003,000 | 1,504,000 | 833,000 | 753,000 | 792,000 | 838,000 | 618,000 | 1,144,000 | 1,192,000 | 1,257,000 | 678,814 | 840,155 |
| net assets | 6,564,000 | 7,677,000 | 7,149,000 | 7,287,000 | 6,914,000 | 8,535,000 | 9,687,000 | 10,215,000 | 10,067,000 | 9,797,000 | 9,083,000 | 7,860,000 | 5,696,000 | 5,602,414 | 4,496,604 |
| total shareholders funds | 6,564,000 | 7,677,000 | 7,149,000 | 7,287,000 | 6,914,000 | 8,535,000 | 9,687,000 | 10,215,000 | 10,067,000 | 9,797,000 | 9,083,000 | 7,860,000 | 5,696,000 | 5,602,414 | 4,496,604 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 138,000 | 115,000 | 168,000 | 206,000 | 277,000 | 229,000 | 214,000 | 236,000 | 229,000 | 213,000 | 158,000 | 150,000 | 163,000 | 166,095 | 178,113 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 8,000 | 11,000 | -10,000 | -17,000 | -22,000 | 8,000 | 8,000 | 14,000 | 7,000 | 44,000 | 2,000 | -2,000 | 495 | 5,443 | 6,062 |
| Debtors | 229,000 | -1,043,000 | 639,000 | -96,000 | 604,000 | -95,000 | -498,000 | 274,000 | -544,000 | 651,000 | -140,000 | 297,000 | 270,001 | 22,711 | 115,288 |
| Creditors | 10,000 | -19,000 | 118,000 | -47,000 | -66,000 | 95,000 | -278,000 | -48,000 | 165,000 | -55,000 | 32,000 | 15,000 | 8,322 | -43,185 | 222,863 |
| Accruals and Deferred Income | 45,000 | -422,000 | -6,000 | -454,000 | 737,000 | -15,000 | 239,000 | 2,000 | 55,000 | -217,000 | 174,000 | -8,000 | -10,136 | -18,156 | 517,292 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | 1,207,000 | -347,000 | -26,000 | -801,000 | -1,453,000 | -1,547,000 | -194,000 | -96,000 | -544,680 | -512,613 |
| Change in Investments | -941,000 | -76,000 | 338,000 | 201,000 | -870,000 | -1,185,000 | 164,000 | 875,000 | 306,000 | 1,306,000 | 1,141,000 | 303,000 | -24,848 | 73,263 | 1,727,585 |
| cash flow from investments | 941,000 | 76,000 | -338,000 | -201,000 | 870,000 | 2,392,000 | -511,000 | -901,000 | -1,107,000 | -2,759,000 | -2,688,000 | -497,000 | -71,152 | -617,943 | -2,240,198 |
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | -300,000 | 75,000 | 225,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -1,000,000 | -275,000 | 1,275,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -254,000 | -254,000 | -72,000 | 580,000 | -100,000 | 100,000 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | -1,172,000 | -276,000 | 1,838,000 | 651,000 | 242,000 | 231,000 | 97,000 | 643,000 | -110,000 | 7,672,000 | -146,000 | 93,000 | 567,586 | -15,786 | 4,342,526 |
| cash and cash equivalents | |||||||||||||||
| cash | -1,644,000 | 1,088,000 | 806,000 | -26,000 | -397,000 | 240,000 | -299,000 | -727,000 | 466,000 | -1,942,000 | -181,000 | 1,608,000 | 490,836 | 465,910 | 971,254 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,644,000 | 1,088,000 | 806,000 | -26,000 | -397,000 | 240,000 | -299,000 | -727,000 | 466,000 | -1,942,000 | -181,000 | 1,608,000 | 490,836 | 465,910 | 971,254 |
prospect hospice limited Credit Report and Business Information
Prospect Hospice Limited Competitor Analysis
Perform a competitor analysis for prospect hospice limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in SN4 area or any other competitors across 12 key performance metrics.
prospect hospice limited Ownership
PROSPECT HOSPICE LIMITED group structure
Prospect Hospice Limited has 1 subsidiary company.
Ultimate parent company
PROSPECT HOSPICE LIMITED
01494909
1 subsidiary
prospect hospice limited directors
Prospect Hospice Limited currently has 12 directors. The longest serving directors include Mrs Sarah Jones (Jul 2018) and Mr John Gilbert (Jul 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Sarah Jones | 48 years | Jul 2018 | - | Director | |
| Mr John Gilbert | 64 years | Jul 2019 | - | Director | |
| Dr Helen Jones | 64 years | Sep 2022 | - | Director | |
| Mrs Julie-Anne Marshman | 59 years | Sep 2022 | - | Director | |
| Mr Nigel Sully | 55 years | May 2023 | - | Director | |
| Ms Sadie Panter | 45 years | May 2023 | - | Director | |
| Ms Carys Ritchie | 49 years | Aug 2023 | - | Director | |
| Ms Philomena Creffield | 55 years | Jan 2024 | - | Director | |
| Mr Nathan Bishop | 35 years | Jan 2024 | - | Director | |
| Mr Peter Cadman | 73 years | Jan 2024 | - | Director |
P&L
March 2024turnover
7.4m
-9%
operating profit
-1.3m
0%
gross margin
38.2%
+5.9%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
6.6m
-0.14%
total assets
7.3m
-0.24%
cash
920k
-0.64%
net assets
Total assets minus all liabilities
Similar Companies
prospect hospice limited company details
company number
01494909
Type
Private Ltd By Guarantee w/o Share Cap
industry
86101 - Hospital activities
86900 - Other human health activities
incorporation date
May 1980
age
44
accounts
Group
ultimate parent company
previous names
prospect foundation limited (November 2007)
incorporated
UK
address
moormead road wroughton, swindon, wiltshire, SN4 9BY
last accounts submitted
March 2024
prospect hospice limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to prospect hospice limited. Currently there are 2 open charges and 0 have been satisfied in the past.
prospect hospice limited Companies House Filings - See Documents
| date | description | view/download |
|---|
